nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—P-Glycoprotein Inhibitors—Crizotinib—lung cancer	0.558	1	CiPCiCtD
Lomitapide—ABCB1—lung cancer	0.126	1	CbGaD
Lomitapide—ABCB1—Topotecan—lung cancer	0.0181	0.0864	CbGbCtD
Lomitapide—ABCB1—Gefitinib—lung cancer	0.0165	0.079	CbGbCtD
Lomitapide—ABCB1—Vinorelbine—lung cancer	0.0127	0.0609	CbGbCtD
Lomitapide—CYP3A4—Topotecan—lung cancer	0.0108	0.0518	CbGbCtD
Lomitapide—ABCB1—Crizotinib—lung cancer	0.0101	0.0484	CbGbCtD
Lomitapide—CYP3A4—Gefitinib—lung cancer	0.00991	0.0473	CbGbCtD
Lomitapide—ABCB1—Gemcitabine—lung cancer	0.00991	0.0473	CbGbCtD
Lomitapide—ABCB1—Erlotinib—lung cancer	0.00978	0.0467	CbGbCtD
Lomitapide—CYP3A4—Teniposide—lung cancer	0.00961	0.0459	CbGbCtD
Lomitapide—ABCB1—Paclitaxel—lung cancer	0.00896	0.0428	CbGbCtD
Lomitapide—ABCB1—Irinotecan—lung cancer	0.00883	0.0422	CbGbCtD
Lomitapide—ABCB1—Vinblastine—lung cancer	0.00785	0.0375	CbGbCtD
Lomitapide—CYP3A4—Vinorelbine—lung cancer	0.00764	0.0365	CbGbCtD
Lomitapide—ABCB1—Cisplatin—lung cancer	0.0072	0.0344	CbGbCtD
Lomitapide—ABCB1—Etoposide—lung cancer	0.00708	0.0338	CbGbCtD
Lomitapide—ABCB1—Docetaxel—lung cancer	0.00647	0.0309	CbGbCtD
Lomitapide—CYP3A4—Crizotinib—lung cancer	0.00608	0.029	CbGbCtD
Lomitapide—CYP3A4—Erlotinib—lung cancer	0.00586	0.028	CbGbCtD
Lomitapide—CYP3A4—Paclitaxel—lung cancer	0.00537	0.0256	CbGbCtD
Lomitapide—CYP3A4—Irinotecan—lung cancer	0.00529	0.0253	CbGbCtD
Lomitapide—ABCB1—Doxorubicin—lung cancer	0.00483	0.023	CbGbCtD
Lomitapide—CYP3A4—Vinblastine—lung cancer	0.00471	0.0225	CbGbCtD
Lomitapide—ABCB1—Methotrexate—lung cancer	0.00468	0.0223	CbGbCtD
Lomitapide—CYP3A4—Etoposide—lung cancer	0.00424	0.0202	CbGbCtD
Lomitapide—CYP3A4—Docetaxel—lung cancer	0.00388	0.0185	CbGbCtD
Lomitapide—CYP3A4—Doxorubicin—lung cancer	0.00289	0.0138	CbGbCtD
Lomitapide—Antrafenine—PTGS2—lung cancer	0.000365	0.751	CrCbGaD
Lomitapide—Fexofenadine—ABCB1—lung cancer	0.000121	0.249	CrCbGaD
Lomitapide—Infection—Cisplatin—lung cancer	6.39e-05	0.000811	CcSEcCtD
Lomitapide—Vomiting—Topotecan—lung cancer	6.38e-05	0.00081	CcSEcCtD
Lomitapide—Malaise—Paclitaxel—lung cancer	6.38e-05	0.00081	CcSEcCtD
Lomitapide—Paraesthesia—Irinotecan—lung cancer	6.36e-05	0.000807	CcSEcCtD
Lomitapide—Vertigo—Paclitaxel—lung cancer	6.36e-05	0.000807	CcSEcCtD
Lomitapide—Vomiting—Erlotinib—lung cancer	6.32e-05	0.000801	CcSEcCtD
Lomitapide—Nervous system disorder—Cisplatin—lung cancer	6.31e-05	0.0008	CcSEcCtD
Lomitapide—Somnolence—Irinotecan—lung cancer	6.3e-05	0.000799	CcSEcCtD
Lomitapide—Headache—Topotecan—lung cancer	6.29e-05	0.000798	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Gemcitabine—lung cancer	6.29e-05	0.000798	CcSEcCtD
Lomitapide—Palpitations—Paclitaxel—lung cancer	6.26e-05	0.000794	CcSEcCtD
Lomitapide—Skin disorder—Cisplatin—lung cancer	6.25e-05	0.000793	CcSEcCtD
Lomitapide—Dyspepsia—Irinotecan—lung cancer	6.24e-05	0.000791	CcSEcCtD
Lomitapide—Headache—Erlotinib—lung cancer	6.22e-05	0.00079	CcSEcCtD
Lomitapide—Pain in extremity—Doxorubicin—lung cancer	6.22e-05	0.000789	CcSEcCtD
Lomitapide—Hyperhidrosis—Cisplatin—lung cancer	6.22e-05	0.000789	CcSEcCtD
Lomitapide—Mediastinal disorder—Docetaxel—lung cancer	6.21e-05	0.000788	CcSEcCtD
Lomitapide—Paraesthesia—Gemcitabine—lung cancer	6.2e-05	0.000786	CcSEcCtD
Lomitapide—Chills—Docetaxel—lung cancer	6.19e-05	0.000785	CcSEcCtD
Lomitapide—Asthenia—Vinorelbine—lung cancer	6.16e-05	0.000782	CcSEcCtD
Lomitapide—Decreased appetite—Irinotecan—lung cancer	6.16e-05	0.000781	CcSEcCtD
Lomitapide—Chest pain—Etoposide—lung cancer	6.15e-05	0.00078	CcSEcCtD
Lomitapide—Nausea—Vinblastine—lung cancer	6.14e-05	0.000779	CcSEcCtD
Lomitapide—Somnolence—Gemcitabine—lung cancer	6.14e-05	0.000778	CcSEcCtD
Lomitapide—Migraine—Doxorubicin—lung cancer	6.12e-05	0.000777	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Irinotecan—lung cancer	6.12e-05	0.000776	CcSEcCtD
Lomitapide—Fatigue—Irinotecan—lung cancer	6.11e-05	0.000775	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	6.1e-05	0.000775	CcSEcCtD
Lomitapide—Discomfort—Etoposide—lung cancer	6.07e-05	0.000771	CcSEcCtD
Lomitapide—Constipation—Irinotecan—lung cancer	6.06e-05	0.000769	CcSEcCtD
Lomitapide—Chest pain—Paclitaxel—lung cancer	6.03e-05	0.000765	CcSEcCtD
Lomitapide—Myalgia—Paclitaxel—lung cancer	6.03e-05	0.000765	CcSEcCtD
Lomitapide—Arthralgia—Paclitaxel—lung cancer	6.03e-05	0.000765	CcSEcCtD
Lomitapide—Malnutrition—Docetaxel—lung cancer	6e-05	0.000761	CcSEcCtD
Lomitapide—Decreased appetite—Gemcitabine—lung cancer	6e-05	0.000761	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	5.99e-05	0.000759	CcSEcCtD
Lomitapide—Nausea—Topotecan—lung cancer	5.96e-05	0.000757	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Gemcitabine—lung cancer	5.96e-05	0.000756	CcSEcCtD
Lomitapide—Discomfort—Paclitaxel—lung cancer	5.96e-05	0.000756	CcSEcCtD
Lomitapide—Abdominal discomfort—Methotrexate—lung cancer	5.95e-05	0.000755	CcSEcCtD
Lomitapide—Fatigue—Gemcitabine—lung cancer	5.95e-05	0.000755	CcSEcCtD
Lomitapide—Constipation—Gemcitabine—lung cancer	5.9e-05	0.000749	CcSEcCtD
Lomitapide—Nausea—Erlotinib—lung cancer	5.9e-05	0.000749	CcSEcCtD
Lomitapide—Dry mouth—Paclitaxel—lung cancer	5.89e-05	0.000748	CcSEcCtD
Lomitapide—Diarrhoea—Vinorelbine—lung cancer	5.88e-05	0.000746	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Cisplatin—lung cancer	5.86e-05	0.000744	CcSEcCtD
Lomitapide—Infection—Etoposide—lung cancer	5.85e-05	0.000743	CcSEcCtD
Lomitapide—Feeling abnormal—Irinotecan—lung cancer	5.84e-05	0.000741	CcSEcCtD
Lomitapide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	5.84e-05	0.00213	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GCLC—lung cancer	5.81e-05	0.00212	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP2A6—lung cancer	5.81e-05	0.00212	CbGpPWpGaD
Lomitapide—Back pain—Docetaxel—lung cancer	5.8e-05	0.000736	CcSEcCtD
Lomitapide—Gastrointestinal pain—Irinotecan—lung cancer	5.79e-05	0.000735	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.79e-05	0.00211	CbGpPWpGaD
Lomitapide—Dehydration—Doxorubicin—lung cancer	5.78e-05	0.000734	CcSEcCtD
Lomitapide—Paraesthesia—Cisplatin—lung cancer	5.78e-05	0.000733	CcSEcCtD
Lomitapide—Muscle spasms—Docetaxel—lung cancer	5.77e-05	0.000732	CcSEcCtD
Lomitapide—Liver function test abnormal—Doxorubicin—lung cancer	5.74e-05	0.000728	CcSEcCtD
Lomitapide—Infection—Paclitaxel—lung cancer	5.74e-05	0.000728	CcSEcCtD
Lomitapide—Skin disorder—Etoposide—lung cancer	5.72e-05	0.000726	CcSEcCtD
Lomitapide—Dry skin—Doxorubicin—lung cancer	5.7e-05	0.000723	CcSEcCtD
Lomitapide—Hyperhidrosis—Etoposide—lung cancer	5.7e-05	0.000723	CcSEcCtD
Lomitapide—Feeling abnormal—Gemcitabine—lung cancer	5.69e-05	0.000722	CcSEcCtD
Lomitapide—Dizziness—Vinorelbine—lung cancer	5.68e-05	0.000721	CcSEcCtD
Lomitapide—Abdominal pain upper—Doxorubicin—lung cancer	5.68e-05	0.000721	CcSEcCtD
Lomitapide—Nervous system disorder—Paclitaxel—lung cancer	5.67e-05	0.000719	CcSEcCtD
Lomitapide—Skin disorder—Paclitaxel—lung cancer	5.61e-05	0.000712	CcSEcCtD
Lomitapide—Abdominal pain—Irinotecan—lung cancer	5.6e-05	0.000711	CcSEcCtD
Lomitapide—Body temperature increased—Irinotecan—lung cancer	5.6e-05	0.000711	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Doxorubicin—lung cancer	5.6e-05	0.000711	CcSEcCtD
Lomitapide—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	5.59e-05	0.00204	CbGpPWpGaD
Lomitapide—Decreased appetite—Cisplatin—lung cancer	5.59e-05	0.000709	CcSEcCtD
Lomitapide—Hyperhidrosis—Paclitaxel—lung cancer	5.59e-05	0.000709	CcSEcCtD
Lomitapide—Nasopharyngitis—Doxorubicin—lung cancer	5.56e-05	0.000706	CcSEcCtD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	5.56e-05	0.00203	CbGpPWpGaD
Lomitapide—Gastrointestinal disorder—Cisplatin—lung cancer	5.55e-05	0.000705	CcSEcCtD
Lomitapide—Anaemia—Docetaxel—lung cancer	5.55e-05	0.000704	CcSEcCtD
Lomitapide—Infestation—Methotrexate—lung cancer	5.53e-05	0.000702	CcSEcCtD
Lomitapide—Infestation NOS—Methotrexate—lung cancer	5.53e-05	0.000702	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—RHEB—lung cancer	5.53e-05	0.00202	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ENO1—lung cancer	5.51e-05	0.00201	CbGpPWpGaD
Lomitapide—Gastritis—Doxorubicin—lung cancer	5.5e-05	0.000698	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.49e-05	0.002	CbGpPWpGaD
Lomitapide—Alanine aminotransferase increased—Doxorubicin—lung cancer	5.48e-05	0.000696	CcSEcCtD
Lomitapide—Vomiting—Vinorelbine—lung cancer	5.46e-05	0.000693	CcSEcCtD
Lomitapide—Body temperature increased—Gemcitabine—lung cancer	5.46e-05	0.000692	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.42e-05	0.00198	CbGpPWpGaD
Lomitapide—Abdominal distension—Doxorubicin—lung cancer	5.41e-05	0.000687	CcSEcCtD
Lomitapide—Headache—Vinorelbine—lung cancer	5.38e-05	0.000683	CcSEcCtD
Lomitapide—Influenza—Doxorubicin—lung cancer	5.37e-05	0.000682	CcSEcCtD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	5.32e-05	0.00194	CbGpPWpGaD
Lomitapide—Palpitations—Docetaxel—lung cancer	5.3e-05	0.000673	CcSEcCtD
Lomitapide—Feeling abnormal—Cisplatin—lung cancer	5.3e-05	0.000673	CcSEcCtD
Lomitapide—Paraesthesia—Etoposide—lung cancer	5.29e-05	0.000671	CcSEcCtD
Lomitapide—Haematuria—Methotrexate—lung cancer	5.28e-05	0.00067	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Paclitaxel—lung cancer	5.26e-05	0.000668	CcSEcCtD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	5.25e-05	0.00192	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—lung cancer	5.25e-05	0.00192	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—lung cancer	5.25e-05	0.00192	CbGpPWpGaD
Lomitapide—Somnolence—Etoposide—lung cancer	5.24e-05	0.000665	CcSEcCtD
Lomitapide—Angina pectoris—Doxorubicin—lung cancer	5.24e-05	0.000664	CcSEcCtD
Lomitapide—Hepatobiliary disease—Methotrexate—lung cancer	5.23e-05	0.000664	CcSEcCtD
Lomitapide—Paraesthesia—Paclitaxel—lung cancer	5.19e-05	0.000658	CcSEcCtD
Lomitapide—Somnolence—Paclitaxel—lung cancer	5.14e-05	0.000652	CcSEcCtD
Lomitapide—Decreased appetite—Etoposide—lung cancer	5.12e-05	0.00065	CcSEcCtD
Lomitapide—Chest pain—Docetaxel—lung cancer	5.11e-05	0.000648	CcSEcCtD
Lomitapide—Myalgia—Docetaxel—lung cancer	5.11e-05	0.000648	CcSEcCtD
Lomitapide—Arthralgia—Docetaxel—lung cancer	5.11e-05	0.000648	CcSEcCtD
Lomitapide—Nausea—Vinorelbine—lung cancer	5.1e-05	0.000647	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Etoposide—lung cancer	5.09e-05	0.000646	CcSEcCtD
Lomitapide—Dyspepsia—Paclitaxel—lung cancer	5.09e-05	0.000645	CcSEcCtD
Lomitapide—Body temperature increased—Cisplatin—lung cancer	5.08e-05	0.000645	CcSEcCtD
Lomitapide—Asthenia—Irinotecan—lung cancer	5.08e-05	0.000645	CcSEcCtD
Lomitapide—Fatigue—Etoposide—lung cancer	5.08e-05	0.000645	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	5.07e-05	0.000644	CcSEcCtD
Lomitapide—Constipation—Etoposide—lung cancer	5.04e-05	0.000639	CcSEcCtD
Lomitapide—Decreased appetite—Paclitaxel—lung cancer	5.02e-05	0.000637	CcSEcCtD
Lomitapide—Dry mouth—Docetaxel—lung cancer	5e-05	0.000634	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Paclitaxel—lung cancer	4.99e-05	0.000633	CcSEcCtD
Lomitapide—Fatigue—Paclitaxel—lung cancer	4.98e-05	0.000632	CcSEcCtD
Lomitapide—Asthenia—Gemcitabine—lung cancer	4.95e-05	0.000628	CcSEcCtD
Lomitapide—Constipation—Paclitaxel—lung cancer	4.94e-05	0.000627	CcSEcCtD
Lomitapide—MTTP—Metabolism—CYP2E1—lung cancer	4.94e-05	0.0018	CbGpPWpGaD
Lomitapide—Urinary tract disorder—Methotrexate—lung cancer	4.91e-05	0.000623	CcSEcCtD
Lomitapide—MTTP—Metabolism—NQO1—lung cancer	4.88e-05	0.00178	CbGpPWpGaD
Lomitapide—Urethral disorder—Methotrexate—lung cancer	4.87e-05	0.000618	CcSEcCtD
Lomitapide—Infection—Docetaxel—lung cancer	4.87e-05	0.000617	CcSEcCtD
Lomitapide—Weight decreased—Doxorubicin—lung cancer	4.86e-05	0.000617	CcSEcCtD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—lung cancer	4.86e-05	0.00177	CbGpPWpGaD
Lomitapide—Feeling abnormal—Etoposide—lung cancer	4.86e-05	0.000616	CcSEcCtD
Lomitapide—Diarrhoea—Irinotecan—lung cancer	4.85e-05	0.000615	CcSEcCtD
Lomitapide—Gastrointestinal pain—Etoposide—lung cancer	4.82e-05	0.000611	CcSEcCtD
Lomitapide—Nervous system disorder—Docetaxel—lung cancer	4.8e-05	0.000609	CcSEcCtD
Lomitapide—Infestation—Doxorubicin—lung cancer	4.79e-05	0.000608	CcSEcCtD
Lomitapide—Infestation NOS—Doxorubicin—lung cancer	4.79e-05	0.000608	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.78e-05	0.00175	CbGpPWpGaD
Lomitapide—Feeling abnormal—Paclitaxel—lung cancer	4.76e-05	0.000604	CcSEcCtD
Lomitapide—Skin disorder—Docetaxel—lung cancer	4.76e-05	0.000604	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.74e-05	0.00173	CbGpPWpGaD
Lomitapide—Gastrointestinal pain—Paclitaxel—lung cancer	4.72e-05	0.000599	CcSEcCtD
Lomitapide—Diarrhoea—Gemcitabine—lung cancer	4.72e-05	0.000599	CcSEcCtD
Lomitapide—Dizziness—Irinotecan—lung cancer	4.68e-05	0.000594	CcSEcCtD
Lomitapide—Abdominal pain—Etoposide—lung cancer	4.66e-05	0.000591	CcSEcCtD
Lomitapide—Body temperature increased—Etoposide—lung cancer	4.66e-05	0.000591	CcSEcCtD
Lomitapide—Eye disorder—Methotrexate—lung cancer	4.64e-05	0.000589	CcSEcCtD
Lomitapide—Asthenia—Cisplatin—lung cancer	4.62e-05	0.000586	CcSEcCtD
Lomitapide—Cardiac disorder—Methotrexate—lung cancer	4.61e-05	0.000585	CcSEcCtD
Lomitapide—Haematuria—Doxorubicin—lung cancer	4.57e-05	0.00058	CcSEcCtD
Lomitapide—Body temperature increased—Paclitaxel—lung cancer	4.57e-05	0.00058	CcSEcCtD
Lomitapide—Abdominal pain—Paclitaxel—lung cancer	4.57e-05	0.00058	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—TERT—lung cancer	4.54e-05	0.00166	CbGpPWpGaD
Lomitapide—Hepatobiliary disease—Doxorubicin—lung cancer	4.53e-05	0.000575	CcSEcCtD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	4.52e-05	0.00165	CbGpPWpGaD
Lomitapide—Vomiting—Irinotecan—lung cancer	4.5e-05	0.000572	CcSEcCtD
Lomitapide—Sinusitis—Doxorubicin—lung cancer	4.5e-05	0.00057	CcSEcCtD
Lomitapide—CYP3A4—Tryptophan metabolism—CAT—lung cancer	4.49e-05	0.00164	CbGpPWpGaD
Lomitapide—Mediastinal disorder—Methotrexate—lung cancer	4.48e-05	0.000568	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—IL10—lung cancer	4.46e-05	0.00163	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	4.46e-05	0.00163	CbGpPWpGaD
Lomitapide—Musculoskeletal discomfort—Docetaxel—lung cancer	4.46e-05	0.000566	CcSEcCtD
Lomitapide—Chills—Methotrexate—lung cancer	4.46e-05	0.000566	CcSEcCtD
Lomitapide—Headache—Irinotecan—lung cancer	4.44e-05	0.000563	CcSEcCtD
Lomitapide—MTTP—Metabolism—STK11—lung cancer	4.4e-05	0.00161	CbGpPWpGaD
Lomitapide—Diarrhoea—Cisplatin—lung cancer	4.4e-05	0.000558	CcSEcCtD
Lomitapide—Paraesthesia—Docetaxel—lung cancer	4.4e-05	0.000558	CcSEcCtD
Lomitapide—Vomiting—Gemcitabine—lung cancer	4.39e-05	0.000557	CcSEcCtD
Lomitapide—CYP3A4—Biological oxidations—GSTM2—lung cancer	4.36e-05	0.00159	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CNDP2—lung cancer	4.36e-05	0.00159	CbGpPWpGaD
Lomitapide—Somnolence—Docetaxel—lung cancer	4.35e-05	0.000552	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—HIF1A—lung cancer	4.34e-05	0.00159	CbGpPWpGaD
Lomitapide—Malnutrition—Methotrexate—lung cancer	4.32e-05	0.000549	CcSEcCtD
Lomitapide—Headache—Gemcitabine—lung cancer	4.32e-05	0.000549	CcSEcCtD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	4.31e-05	0.00157	CbGpPWpGaD
Lomitapide—Dyspepsia—Docetaxel—lung cancer	4.31e-05	0.000547	CcSEcCtD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	4.3e-05	0.00157	CbGpPWpGaD
Lomitapide—Decreased appetite—Docetaxel—lung cancer	4.26e-05	0.00054	CcSEcCtD
Lomitapide—Urinary tract disorder—Doxorubicin—lung cancer	4.25e-05	0.000539	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Docetaxel—lung cancer	4.23e-05	0.000536	CcSEcCtD
Lomitapide—Asthenia—Etoposide—lung cancer	4.23e-05	0.000536	CcSEcCtD
Lomitapide—Connective tissue disorder—Doxorubicin—lung cancer	4.23e-05	0.000536	CcSEcCtD
Lomitapide—Fatigue—Docetaxel—lung cancer	4.22e-05	0.000536	CcSEcCtD
Lomitapide—Urethral disorder—Doxorubicin—lung cancer	4.22e-05	0.000535	CcSEcCtD
Lomitapide—Nausea—Irinotecan—lung cancer	4.21e-05	0.000534	CcSEcCtD
Lomitapide—Constipation—Docetaxel—lung cancer	4.19e-05	0.000531	CcSEcCtD
Lomitapide—Back pain—Methotrexate—lung cancer	4.18e-05	0.000531	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—FASLG—lung cancer	4.15e-05	0.00152	CbGpPWpGaD
Lomitapide—Asthenia—Paclitaxel—lung cancer	4.15e-05	0.000526	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.13e-05	0.00151	CbGpPWpGaD
Lomitapide—Nausea—Gemcitabine—lung cancer	4.1e-05	0.00052	CcSEcCtD
Lomitapide—Vomiting—Cisplatin—lung cancer	4.09e-05	0.000519	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	4.08e-05	0.00149	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTP1—lung cancer	4.07e-05	0.00149	CbGpPWpGaD
Lomitapide—Feeling abnormal—Docetaxel—lung cancer	4.04e-05	0.000512	CcSEcCtD
Lomitapide—Diarrhoea—Etoposide—lung cancer	4.03e-05	0.000512	CcSEcCtD
Lomitapide—Eye disorder—Doxorubicin—lung cancer	4.02e-05	0.00051	CcSEcCtD
Lomitapide—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	4.02e-05	0.00147	CbGpPWpGaD
Lomitapide—Ill-defined disorder—Methotrexate—lung cancer	4.01e-05	0.000509	CcSEcCtD
Lomitapide—Gastrointestinal pain—Docetaxel—lung cancer	4e-05	0.000508	CcSEcCtD
Lomitapide—Anaemia—Methotrexate—lung cancer	4e-05	0.000507	CcSEcCtD
Lomitapide—Cardiac disorder—Doxorubicin—lung cancer	3.99e-05	0.000507	CcSEcCtD
Lomitapide—MTTP—Metabolism—CAT—lung cancer	3.96e-05	0.00145	CbGpPWpGaD
Lomitapide—Diarrhoea—Paclitaxel—lung cancer	3.95e-05	0.000502	CcSEcCtD
Lomitapide—CYP3A4—Biological oxidations—CYP2A7—lung cancer	3.94e-05	0.00144	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.94e-05	0.00144	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC34A2—lung cancer	3.9e-05	0.00142	CbGpPWpGaD
Lomitapide—Malaise—Methotrexate—lung cancer	3.9e-05	0.000495	CcSEcCtD
Lomitapide—Dizziness—Etoposide—lung cancer	3.9e-05	0.000494	CcSEcCtD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	3.89e-05	0.00142	CbGpPWpGaD
Lomitapide—Vertigo—Methotrexate—lung cancer	3.89e-05	0.000493	CcSEcCtD
Lomitapide—Mediastinal disorder—Doxorubicin—lung cancer	3.88e-05	0.000492	CcSEcCtD
Lomitapide—Body temperature increased—Docetaxel—lung cancer	3.87e-05	0.000491	CcSEcCtD
Lomitapide—Abdominal pain—Docetaxel—lung cancer	3.87e-05	0.000491	CcSEcCtD
Lomitapide—Chills—Doxorubicin—lung cancer	3.86e-05	0.00049	CcSEcCtD
Lomitapide—MTTP—Metabolism—ABCB1—lung cancer	3.86e-05	0.00141	CbGpPWpGaD
Lomitapide—Dizziness—Paclitaxel—lung cancer	3.82e-05	0.000485	CcSEcCtD
Lomitapide—Nausea—Cisplatin—lung cancer	3.82e-05	0.000485	CcSEcCtD
Lomitapide—MTTP—Metabolism—TYMS—lung cancer	3.79e-05	0.00138	CbGpPWpGaD
Lomitapide—Vomiting—Etoposide—lung cancer	3.75e-05	0.000475	CcSEcCtD
Lomitapide—Malnutrition—Doxorubicin—lung cancer	3.74e-05	0.000475	CcSEcCtD
Lomitapide—MTTP—Metabolism—GSTM1—lung cancer	3.74e-05	0.00137	CbGpPWpGaD
Lomitapide—Headache—Etoposide—lung cancer	3.69e-05	0.000468	CcSEcCtD
Lomitapide—Flatulence—Doxorubicin—lung cancer	3.69e-05	0.000468	CcSEcCtD
Lomitapide—Chest pain—Methotrexate—lung cancer	3.68e-05	0.000467	CcSEcCtD
Lomitapide—Myalgia—Methotrexate—lung cancer	3.68e-05	0.000467	CcSEcCtD
Lomitapide—Arthralgia—Methotrexate—lung cancer	3.68e-05	0.000467	CcSEcCtD
Lomitapide—Vomiting—Paclitaxel—lung cancer	3.67e-05	0.000466	CcSEcCtD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	3.67e-05	0.00134	CbGpPWpGaD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.66e-05	0.000464	CcSEcCtD
Lomitapide—Discomfort—Methotrexate—lung cancer	3.64e-05	0.000462	CcSEcCtD
Lomitapide—Back pain—Doxorubicin—lung cancer	3.62e-05	0.00046	CcSEcCtD
Lomitapide—Headache—Paclitaxel—lung cancer	3.62e-05	0.000459	CcSEcCtD
Lomitapide—Muscle spasms—Doxorubicin—lung cancer	3.6e-05	0.000457	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	3.57e-05	0.0013	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP1A1—lung cancer	3.55e-05	0.0013	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—CREBBP—lung cancer	3.55e-05	0.0013	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ERCC2—lung cancer	3.52e-05	0.00129	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTA3—lung cancer	3.51e-05	0.00128	CbGpPWpGaD
Lomitapide—Asthenia—Docetaxel—lung cancer	3.51e-05	0.000446	CcSEcCtD
Lomitapide—Infection—Methotrexate—lung cancer	3.51e-05	0.000445	CcSEcCtD
Lomitapide—Nausea—Etoposide—lung cancer	3.5e-05	0.000444	CcSEcCtD
Lomitapide—Ill-defined disorder—Doxorubicin—lung cancer	3.47e-05	0.000441	CcSEcCtD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	3.47e-05	0.00127	CbGpPWpGaD
Lomitapide—Nervous system disorder—Methotrexate—lung cancer	3.46e-05	0.000439	CcSEcCtD
Lomitapide—Anaemia—Doxorubicin—lung cancer	3.46e-05	0.000439	CcSEcCtD
Lomitapide—Nausea—Paclitaxel—lung cancer	3.43e-05	0.000435	CcSEcCtD
Lomitapide—Skin disorder—Methotrexate—lung cancer	3.43e-05	0.000435	CcSEcCtD
Lomitapide—Hyperhidrosis—Methotrexate—lung cancer	3.41e-05	0.000433	CcSEcCtD
Lomitapide—Malaise—Doxorubicin—lung cancer	3.38e-05	0.000429	CcSEcCtD
Lomitapide—Vertigo—Doxorubicin—lung cancer	3.36e-05	0.000427	CcSEcCtD
Lomitapide—Diarrhoea—Docetaxel—lung cancer	3.35e-05	0.000425	CcSEcCtD
Lomitapide—Palpitations—Doxorubicin—lung cancer	3.31e-05	0.00042	CcSEcCtD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	3.25e-05	0.00119	CbGpPWpGaD
Lomitapide—Dizziness—Docetaxel—lung cancer	3.24e-05	0.000411	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Methotrexate—lung cancer	3.22e-05	0.000408	CcSEcCtD
Lomitapide—CYP3A4—Biological oxidations—GSTA4—lung cancer	3.21e-05	0.00117	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	3.21e-05	0.00117	CbGpPWpGaD
Lomitapide—Arthralgia—Doxorubicin—lung cancer	3.19e-05	0.000405	CcSEcCtD
Lomitapide—Chest pain—Doxorubicin—lung cancer	3.19e-05	0.000405	CcSEcCtD
Lomitapide—Myalgia—Doxorubicin—lung cancer	3.19e-05	0.000405	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	3.18e-05	0.00116	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	3.17e-05	0.00116	CbGpPWpGaD
Lomitapide—Paraesthesia—Methotrexate—lung cancer	3.17e-05	0.000402	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.17e-05	0.000402	CcSEcCtD
Lomitapide—Discomfort—Doxorubicin—lung cancer	3.15e-05	0.0004	CcSEcCtD
Lomitapide—Somnolence—Methotrexate—lung cancer	3.14e-05	0.000398	CcSEcCtD
Lomitapide—CYP3A4—Biological oxidations—GSTA2—lung cancer	3.13e-05	0.00114	CbGpPWpGaD
Lomitapide—Dry mouth—Doxorubicin—lung cancer	3.12e-05	0.000396	CcSEcCtD
Lomitapide—Vomiting—Docetaxel—lung cancer	3.11e-05	0.000395	CcSEcCtD
Lomitapide—Dyspepsia—Methotrexate—lung cancer	3.11e-05	0.000394	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—CASP8—lung cancer	3.09e-05	0.00113	CbGpPWpGaD
Lomitapide—Decreased appetite—Methotrexate—lung cancer	3.07e-05	0.000389	CcSEcCtD
Lomitapide—Headache—Docetaxel—lung cancer	3.07e-05	0.000389	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Methotrexate—lung cancer	3.05e-05	0.000387	CcSEcCtD
Lomitapide—MTTP—Metabolism—APOA1—lung cancer	3.05e-05	0.00111	CbGpPWpGaD
Lomitapide—Fatigue—Methotrexate—lung cancer	3.04e-05	0.000386	CcSEcCtD
Lomitapide—Infection—Doxorubicin—lung cancer	3.04e-05	0.000385	CcSEcCtD
Lomitapide—CYP3A4—Biological oxidations—GSTA1—lung cancer	3.02e-05	0.0011	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	3.01e-05	0.0011	CbGpPWpGaD
Lomitapide—Nervous system disorder—Doxorubicin—lung cancer	3e-05	0.00038	CcSEcCtD
Lomitapide—Skin disorder—Doxorubicin—lung cancer	2.97e-05	0.000377	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC22A18—lung cancer	2.96e-05	0.00108	CbGpPWpGaD
Lomitapide—Hyperhidrosis—Doxorubicin—lung cancer	2.95e-05	0.000375	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.92e-05	0.00106	CbGpPWpGaD
Lomitapide—Nausea—Docetaxel—lung cancer	2.91e-05	0.000369	CcSEcCtD
Lomitapide—Feeling abnormal—Methotrexate—lung cancer	2.91e-05	0.000369	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methotrexate—lung cancer	2.89e-05	0.000366	CcSEcCtD
Lomitapide—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	2.85e-05	0.00104	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	2.85e-05	0.00104	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—UGT1A1—lung cancer	2.81e-05	0.00103	CbGpPWpGaD
Lomitapide—Body temperature increased—Methotrexate—lung cancer	2.79e-05	0.000354	CcSEcCtD
Lomitapide—Abdominal pain—Methotrexate—lung cancer	2.79e-05	0.000354	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.78e-05	0.000353	CcSEcCtD
Lomitapide—MTTP—Metabolism—PIK3CG—lung cancer	2.78e-05	0.00102	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	2.77e-05	0.00101	CbGpPWpGaD
Lomitapide—Paraesthesia—Doxorubicin—lung cancer	2.74e-05	0.000348	CcSEcCtD
Lomitapide—Somnolence—Doxorubicin—lung cancer	2.72e-05	0.000345	CcSEcCtD
Lomitapide—Dyspepsia—Doxorubicin—lung cancer	2.69e-05	0.000341	CcSEcCtD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	2.67e-05	0.000976	CbGpPWpGaD
Lomitapide—Decreased appetite—Doxorubicin—lung cancer	2.66e-05	0.000337	CcSEcCtD
Lomitapide—MTTP—Metabolism—POMC—lung cancer	2.65e-05	0.000966	CbGpPWpGaD
Lomitapide—Gastrointestinal disorder—Doxorubicin—lung cancer	2.64e-05	0.000335	CcSEcCtD
Lomitapide—Fatigue—Doxorubicin—lung cancer	2.64e-05	0.000334	CcSEcCtD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	2.63e-05	0.000962	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—JUN—lung cancer	2.62e-05	0.000957	CbGpPWpGaD
Lomitapide—Constipation—Doxorubicin—lung cancer	2.61e-05	0.000332	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	2.59e-05	0.000946	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CREBBP—lung cancer	2.58e-05	0.000941	CbGpPWpGaD
Lomitapide—Asthenia—Methotrexate—lung cancer	2.53e-05	0.000321	CcSEcCtD
Lomitapide—Feeling abnormal—Doxorubicin—lung cancer	2.52e-05	0.00032	CcSEcCtD
Lomitapide—Gastrointestinal pain—Doxorubicin—lung cancer	2.5e-05	0.000317	CcSEcCtD
Lomitapide—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	2.48e-05	0.000905	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CD—lung cancer	2.44e-05	0.000893	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CXCL8—lung cancer	2.44e-05	0.000891	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	2.42e-05	0.000885	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	2.42e-05	0.000883	CbGpPWpGaD
Lomitapide—Abdominal pain—Doxorubicin—lung cancer	2.42e-05	0.000307	CcSEcCtD
Lomitapide—Body temperature increased—Doxorubicin—lung cancer	2.42e-05	0.000307	CcSEcCtD
Lomitapide—Diarrhoea—Methotrexate—lung cancer	2.42e-05	0.000306	CcSEcCtD
Lomitapide—MTTP—Metabolism—ALB—lung cancer	2.41e-05	0.000881	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—HPGDS—lung cancer	2.39e-05	0.000872	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CASP3—lung cancer	2.34e-05	0.000853	CbGpPWpGaD
Lomitapide—Dizziness—Methotrexate—lung cancer	2.33e-05	0.000296	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—IL2—lung cancer	2.33e-05	0.000852	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTT1—lung cancer	2.32e-05	0.000846	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP2A6—lung cancer	2.29e-05	0.000836	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GCLC—lung cancer	2.29e-05	0.000836	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	2.29e-05	0.000836	CbGpPWpGaD
Lomitapide—Vomiting—Methotrexate—lung cancer	2.24e-05	0.000285	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	2.23e-05	0.000814	CbGpPWpGaD
Lomitapide—Headache—Methotrexate—lung cancer	2.21e-05	0.000281	CcSEcCtD
Lomitapide—Asthenia—Doxorubicin—lung cancer	2.19e-05	0.000278	CcSEcCtD
Lomitapide—MTTP—Metabolism—PIK3CB—lung cancer	2.13e-05	0.000778	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTGS2—lung cancer	2.11e-05	0.000771	CbGpPWpGaD
Lomitapide—Nausea—Methotrexate—lung cancer	2.1e-05	0.000266	CcSEcCtD
Lomitapide—Diarrhoea—Doxorubicin—lung cancer	2.09e-05	0.000265	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	2.05e-05	0.000748	CbGpPWpGaD
Lomitapide—Dizziness—Doxorubicin—lung cancer	2.02e-05	0.000256	CcSEcCtD
Lomitapide—ABCB1—Metabolism—COL4A3BP—lung cancer	2e-05	0.000729	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AZIN2—lung cancer	2e-05	0.000729	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—VEGFA—lung cancer	1.98e-05	0.000724	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	1.96e-05	0.000717	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP2E1—lung cancer	1.95e-05	0.000711	CbGpPWpGaD
Lomitapide—Vomiting—Doxorubicin—lung cancer	1.94e-05	0.000247	CcSEcCtD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	1.92e-05	0.000701	CbGpPWpGaD
Lomitapide—Headache—Doxorubicin—lung cancer	1.91e-05	0.000243	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	1.88e-05	0.000688	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTEN—lung cancer	1.84e-05	0.000672	CbGpPWpGaD
Lomitapide—Nausea—Doxorubicin—lung cancer	1.82e-05	0.00023	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	1.77e-05	0.000647	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—EP300—lung cancer	1.76e-05	0.000641	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ATP5H—lung cancer	1.7e-05	0.00062	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	1.64e-05	0.000597	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	1.62e-05	0.00059	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTP1—lung cancer	1.61e-05	0.000587	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	1.61e-05	0.000586	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	1.58e-05	0.000578	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	1.52e-05	0.000556	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	1.52e-05	0.000554	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PLBD1—lung cancer	1.51e-05	0.000553	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTM1—lung cancer	1.48e-05	0.000539	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	1.46e-05	0.000533	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	1.46e-05	0.000532	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	1.45e-05	0.000529	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	1.44e-05	0.000527	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	1.44e-05	0.000527	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP1A1—lung cancer	1.4e-05	0.000511	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HSD17B10—lung cancer	1.38e-05	0.000506	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	1.38e-05	0.000504	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	1.34e-05	0.00049	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CA—lung cancer	1.3e-05	0.000474	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	1.29e-05	0.00047	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CKB—lung cancer	1.29e-05	0.00047	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	1.28e-05	0.000469	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	1.27e-05	0.000464	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	1.24e-05	0.000454	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.23e-05	0.000449	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AZIN2—lung cancer	1.23e-05	0.000449	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTM2—lung cancer	1.21e-05	0.000442	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CNDP2—lung cancer	1.21e-05	0.000442	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—MTMR3—lung cancer	1.18e-05	0.00043	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.15e-05	0.000421	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PGAM1—lung cancer	1.15e-05	0.000419	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.12e-05	0.00041	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.12e-05	0.000409	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP2A7—lung cancer	1.09e-05	0.0004	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.09e-05	0.000396	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.08e-05	0.000396	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SDC4—lung cancer	1.07e-05	0.000391	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—AKT1—lung cancer	1.06e-05	0.000387	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ATP5H—lung cancer	1.05e-05	0.000382	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—POMC—lung cancer	1.04e-05	0.000381	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.03e-05	0.000377	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1e-05	0.000367	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	9.78e-06	0.000357	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—RRM1—lung cancer	9.75e-06	0.000356	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTA3—lung cancer	9.75e-06	0.000356	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PLBD1—lung cancer	9.33e-06	0.000341	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	9.3e-06	0.00034	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	9.25e-06	0.000338	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—B4GALT5—lung cancer	9.17e-06	0.000335	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	9e-06	0.000329	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTA4—lung cancer	8.92e-06	0.000326	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	8.8e-06	0.000321	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTA2—lung cancer	8.69e-06	0.000318	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HSD17B10—lung cancer	8.53e-06	0.000312	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTA1—lung cancer	8.39e-06	0.000306	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	8.32e-06	0.000304	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ABCC3—lung cancer	8.29e-06	0.000303	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AKR1C1—lung cancer	8.03e-06	0.000293	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CKB—lung cancer	7.93e-06	0.00029	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—UGT1A1—lung cancer	7.8e-06	0.000285	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	7.64e-06	0.000279	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GNG11—lung cancer	7.52e-06	0.000275	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTM2—lung cancer	7.46e-06	0.000272	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CNDP2—lung cancer	7.46e-06	0.000272	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	7.39e-06	0.00027	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—MTMR3—lung cancer	7.25e-06	0.000265	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALDOA—lung cancer	7.16e-06	0.000261	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	7.11e-06	0.00026	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PGAM1—lung cancer	7.07e-06	0.000258	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NCOA3—lung cancer	6.95e-06	0.000254	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ADCY1—lung cancer	6.76e-06	0.000247	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ABCG2—lung cancer	6.76e-06	0.000247	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP2A7—lung cancer	6.74e-06	0.000246	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HPGDS—lung cancer	6.63e-06	0.000242	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ENO2—lung cancer	6.63e-06	0.000242	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SDC4—lung cancer	6.6e-06	0.000241	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPP2R1B—lung cancer	6.59e-06	0.000241	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTT1—lung cancer	6.43e-06	0.000235	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP2A6—lung cancer	6.36e-06	0.000232	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GCLC—lung cancer	6.36e-06	0.000232	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	6.24e-06	0.000228	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ENO1—lung cancer	6.03e-06	0.00022	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	6.02e-06	0.00022	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTA3—lung cancer	6.01e-06	0.000219	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—RRM1—lung cancer	6.01e-06	0.000219	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—B4GALT5—lung cancer	5.65e-06	0.000206	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	5.64e-06	0.000206	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTA4—lung cancer	5.5e-06	0.000201	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP2E1—lung cancer	5.41e-06	0.000197	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTA2—lung cancer	5.36e-06	0.000196	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NQO1—lung cancer	5.34e-06	0.000195	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTA1—lung cancer	5.17e-06	0.000189	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCC3—lung cancer	5.11e-06	0.000187	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	5.1e-06	0.000186	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AKR1C1—lung cancer	4.95e-06	0.000181	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—STK11—lung cancer	4.82e-06	0.000176	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—UGT1A1—lung cancer	4.8e-06	0.000175	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GNG11—lung cancer	4.63e-06	0.000169	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTP1—lung cancer	4.46e-06	0.000163	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALDOA—lung cancer	4.41e-06	0.000161	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CAT—lung cancer	4.34e-06	0.000158	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NCOA3—lung cancer	4.28e-06	0.000156	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ADCY1—lung cancer	4.17e-06	0.000152	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCG2—lung cancer	4.17e-06	0.000152	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—TYMS—lung cancer	4.14e-06	0.000151	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTM1—lung cancer	4.1e-06	0.00015	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ENO2—lung cancer	4.09e-06	0.000149	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HPGDS—lung cancer	4.09e-06	0.000149	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.06e-06	0.000148	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTT1—lung cancer	3.96e-06	0.000145	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GCLC—lung cancer	3.92e-06	0.000143	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP2A6—lung cancer	3.92e-06	0.000143	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP1A1—lung cancer	3.88e-06	0.000142	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ERCC2—lung cancer	3.85e-06	0.000141	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ENO1—lung cancer	3.71e-06	0.000136	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOA1—lung cancer	3.33e-06	0.000122	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP2E1—lung cancer	3.33e-06	0.000122	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NQO1—lung cancer	3.29e-06	0.00012	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CG—lung cancer	3.04e-06	0.000111	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—STK11—lung cancer	2.97e-06	0.000108	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—POMC—lung cancer	2.9e-06	0.000106	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CREBBP—lung cancer	2.82e-06	0.000103	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTP1—lung cancer	2.75e-06	0.0001	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CD—lung cancer	2.67e-06	9.77e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CAT—lung cancer	2.67e-06	9.76e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALB—lung cancer	2.64e-06	9.64e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCB1—lung cancer	2.6e-06	9.49e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—TYMS—lung cancer	2.55e-06	9.32e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTM1—lung cancer	2.52e-06	9.22e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP1A1—lung cancer	2.39e-06	8.74e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ERCC2—lung cancer	2.37e-06	8.67e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CB—lung cancer	2.33e-06	8.51e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGS2—lung cancer	2.31e-06	8.43e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOA1—lung cancer	2.05e-06	7.5e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTEN—lung cancer	2.01e-06	7.36e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—EP300—lung cancer	1.92e-06	7.01e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CG—lung cancer	1.87e-06	6.84e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—POMC—lung cancer	1.78e-06	6.51e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CREBBP—lung cancer	1.74e-06	6.35e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CD—lung cancer	1.65e-06	6.02e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALB—lung cancer	1.63e-06	5.94e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CB—lung cancer	1.44e-06	5.24e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGS2—lung cancer	1.42e-06	5.2e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CA—lung cancer	1.42e-06	5.19e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTEN—lung cancer	1.24e-06	4.53e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—EP300—lung cancer	1.18e-06	4.32e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AKT1—lung cancer	1.16e-06	4.24e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CA—lung cancer	8.75e-07	3.2e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AKT1—lung cancer	7.15e-07	2.61e-05	CbGpPWpGaD
